Drug Patents owned by Noven Pharms Inc

1. Drug name - DAYTRANA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9668981 NOVEN PHARMS INC Device for transdermal administration of drugs including acrylic based polymers Oct, 2025

(3 years from now)

US8632802 NOVEN PHARMS INC Device for transdermal administration of drugs including acrylic polymers Oct, 2025

(3 years from now)

US9034370 NOVEN PHARMS INC Device for transdermal administration of drugs including acrylic polymers Oct, 2025

(3 years from now)

Drugs and Companies using METHYLPHENIDATE ingredient

Treatment: Method for transdermally delivering a drug to a user in need thereof

Dosage: FILM, EXTENDED RELEASE;TRANSDERMAL

More Information on Dosage
Strength Dosage Availability
10MG/9HR (1.1MG/HR) FILM, EXTENDED RELEASE;TRANSDERMAL Prescription
15MG/9HR (1.6MG/HR) FILM, EXTENDED RELEASE;TRANSDERMAL Prescription
20MG/9HR (2.2MG/HR) FILM, EXTENDED RELEASE;TRANSDERMAL Prescription
30MG/9HR (3.3MG/HR) FILM, EXTENDED RELEASE;TRANSDERMAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.